The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global drug discovery informatics market is poised for substantial growth, expected to surge from $2.97 billion in 2022 to $3.32 billion in 2023, reflecting a robust compound annual growth rate (CAGR) of 12.0%. As we look ahead, the market is projected to reach $5.21 billion by 2027, maintaining a CAGR of 11.9%. Let’s delve into the key drivers, major players, and emerging trends that shape the dynamic landscape of drug discovery informatics.

Healing Insights: The Impact of Chronic Diseases

– Chronic Diseases Defined

The upswing in the prevalence of various chronic diseases emerges as a significant driver propelling the growth of the drug discovery informatics market. Chronic illnesses, persisting for a year or more, necessitate ongoing medical attention and can impede daily activities. Drug discovery informatics systems play a pivotal role in advancing chronic illness care by enabling researchers to delve into complex molecular changes underlying disease progression and drug response.

– Global Health Burden

According to the World Health Organization, non-communicable diseases (NCDs) are anticipated to claim 41 million lives in 2022, constituting 74% of all global deaths. Cardiovascular diseases, cancer, chronic respiratory disorders, and diabetes collectively contribute to this burden, with 86% of premature fatalities occurring in low- and middle-income nations. The rising prevalence of chronic diseases underscores the critical role of drug discovery informatics in addressing global health challenges.

Industry Titans: Key Players Shaping the Landscape

– Market Influencers

Major players in the drug discovery informatics market include Accenture Plc., Certara, Charles River Laboratories Inc., Infosys Ltd., and Thermo Fisher Scientific Inc., among others. These industry leaders play a pivotal role in steering the growth trajectory of the drug discovery informatics sector.

Technological Symphony: Advancements in Drug Discovery Informatics

– Technological Advancements

Technological advancements emerge as a key trend gaining prominence in the drug discovery informatics market. Leading companies are actively engaged in developing advanced solutions to sustain and strengthen their market positions.

– Certara’s Stride in Innovation

In January 2021, Certara Inc. introduced version 20 of its Simcyp Physiologically-based Pharmacokinetic (PBPK) Simulator platform. Key features include:

• Maternal Health Models:Enhanced for measuring medicine performance during pregnancy and lactation.
• Clinical Trial Efficiency:Improved by modeling and simulating pharmacokinetics (PK) and pharmacodynamics (PD) using virtual patient populations.
• Predictive Pharmacokinetics:Employed for small molecule and biological drug development.

Market Segmentation: Understanding Diversity

1) By Service

• In-House
• Outsourced

2) By Modality

• Cloud-Based Systems
• In-Campus

3) By Application

• Data Sequencing
• Molecular Docking
• Identification and Validation
• Target Data Analysis

4) By End-User

• Pharmaceutical Companies
• Contract Research Organizations
• Bio-Technology Companies

This detailed segmentation provides insights into the varied services, modalities, applications, and end-users within the drug discovery informatics market.

Regional Dynamics: North America Leading, Asia-Pacific Surging

– Leading Region

In 2022, North America emerged as the largest region in the drug discovery informatics market, reflecting its robust market share and influence.

– Future Growth

Asia-Pacific is anticipated to be the fastest-growing region in the global drug discovery informatics market during the forecast period. The region’s dynamic growth highlights its increasing significance in shaping the future of drug discovery informatics.

View More On The Drug Discovery Informatics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

Request A Sample Of The Global Drug Discovery Informatics Market Report 2023:

https://www.thebusinessresearchcompany.com/sample_request?id=8960&type=smp

The Drug Discovery Informatics Global Market Report 2023  provides comprehensive insights on the drug discovery informatics market size, trends and drivers, opportunities, strategies, and competitor analysis. The countries covered in the drug discovery informatics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2023

CRISPR Technology Global Market Report 2023

RNA Analysis Transcriptomics Global Market Report 2023

Learn More About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/ 
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model